Viewing Study NCT00159666


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-01-27 @ 2:26 AM
Study NCT ID: NCT00159666
Status: COMPLETED
Last Update Posted: 2021-01-22
First Post: 2005-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A0081004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators